Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue.

Lansberg MG, Cereda CW, Mlynash M, Mishra NK, Inoue M, Kemp S, Christensen S, Straka M, Zaharchuk G, Marks MP, Bammer R, Albers GW; Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 (DEFUSE 2) Study Investigators; Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 DEFUSE 2 Study Investigators.

Neurology. 2015 Aug 25;85(8):708-14. doi: 10.1212/WNL.0000000000001853. Epub 2015 Jul 29.

PMID:
26224727
2.

Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort.

Olivot JM, Mlynash M, Inoue M, Marks MP, Wheeler HM, Kemp S, Straka M, Zaharchuk G, Bammer R, Lansberg MG, Albers GW; DEFUSE 2 Investigators.

Stroke. 2014 Apr;45(4):1018-23. doi: 10.1161/STROKEAHA.113.003857. Epub 2014 Mar 4. Erratum in: Stroke. 2014 May;45(5):e92.

3.

SOLITAIREā„¢ with the intention for thrombectomy (SWIFT) trial: design of a randomized, controlled, multicenter study comparing the SOLITAIREā„¢ Flow Restoration device and the MERCI Retriever in acute ischaemic stroke.

Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira R, Clark W, Budzik R, Zaidat OO; SWIFT Trialists.

Int J Stroke. 2014 Jul;9(5):658-68. doi: 10.1111/j.1747-4949.2012.00856.x. Epub 2012 Nov 6.

PMID:
23130938
4.

MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.

Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, Wilder MJ, Lutsep HL, Czartoski TJ, Bernstein RA, Chang CW, Warach S, Fazekas F, Inoue M, Tipirneni A, Hamilton SA, Zaharchuk G, Marks MP, Bammer R, Albers GW; DEFUSE 2 study investigators.

Lancet Neurol. 2012 Oct;11(10):860-7. doi: 10.1016/S1474-4422(12)70203-X. Epub 2012 Sep 4.

5.

Immunomodulatory therapies in neurologic critical care.

McDaneld LM, Fields JD, Bourdette DN, Bhardwaj A.

Neurocrit Care. 2010 Feb;12(1):132-43. doi: 10.1007/s12028-009-9274-0. Epub 2009 Sep 23. Review.

PMID:
19774497
6.

Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells.

Zou W, McDaneld L, Smith LM.

Anticancer Res. 2003 Nov-Dec;23(6C):4581-6.

PMID:
14981899
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk